Target Price | $4.13 |
Price | $0.62 |
Potential |
564.25%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target AcelRx Pharmaceuticals, Inc. 2026 .
The average AcelRx Pharmaceuticals, Inc. target price is $4.13.
This is
564.25%
register free of charge
$6.00
866.18%
register free of charge
$3.00
383.09%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend AcelRx Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AcelRx Pharmaceuticals, Inc. stock has an average upside potential 2026 of
564.25%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.29 | -0.59 |
122.55% | 54.26% | |
P/E | negative |
3 Analysts have issued a AcelRx Pharmaceuticals, Inc. forecast for earnings per share. The average AcelRx Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
AcelRx Pharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.